{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:06:37Z","timestamp":1791875197191,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.heliyon.2023.e22819","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T12:17:58Z","timestamp":1700828278000},"page":"e22819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Falsely elevated serum testosterone measurements resulting from testosterone topical gel contamination of the venipuncture site: Case Series and retrospective review"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-3096","authenticated-orcid":false,"given":"Aranza Pinedo","family":"Pichilingue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina N.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-8402","authenticated-orcid":false,"given":"Matthew D.","family":"Krasowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e22819_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.2016.21041","article-title":"Association between direct-to-consumer advertising and testosterone testing and initiation in the United States, 2009-2013","volume":"317","author":"Layton","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e22819_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1210\/jc.2013-3570","article-title":"Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011","volume":"99","author":"Layton","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2023.e22819_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5534\/wjmh.190166","article-title":"A national analysis of temporal changes in prescribing of testosterone replacement therapy considering methods of delivery and government regulation","volume":"39","author":"Morton","year":"2021","journal-title":"World J Mens Health"},{"key":"10.1016\/j.heliyon.2023.e22819_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JU.0000000000000744","article-title":"Trends and patterns of testosterone therapy among U.S. Male medicare beneficiaries, 1999 to 2014","volume":"203","author":"Zhou","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.heliyon.2023.e22819_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11934-018-0816-x","article-title":"Novel therapy for male hypogonadism","volume":"19","author":"Carrasquillo","year":"2018","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.heliyon.2023.e22819_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1557988314556671","article-title":"An overview of testosterone therapy","volume":"10","author":"Lee","year":"2016","journal-title":"Am. J. Men's Health"},{"key":"10.1016\/j.heliyon.2023.e22819_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ucl.2022.07.010","article-title":"Testosterone replacement options","volume":"49","author":"McCullough","year":"2022","journal-title":"Urol. Clin."},{"key":"10.1016\/j.heliyon.2023.e22819_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/14728214.2016.1226799","article-title":"Emerging medication for the treatment of male hypogonadism","volume":"21","author":"Aydogdu","year":"2016","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.heliyon.2023.e22819_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.euf.2017.10.016","article-title":"Marketing and testosterone treatment in the USA: a systematic review","volume":"3","author":"Bandari","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.heliyon.2023.e22819_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0000000000000412","article-title":"The marketing of testosterone treatments for age-related low testosterone or 'Low T","volume":"25","author":"Mintzes","year":"2018","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.heliyon.2023.e22819_bib11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2023.e22819_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.heliyon.2023.e22819_bib13","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2023.e22819_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17446651.2020.1825075","article-title":"Endocrine treatment of transgender individuals: current guidelines and strategies","volume":"15","author":"Prince","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.heliyon.2023.e22819_bib15","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0112","article-title":"Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations","volume":"11","author":"Madsen","year":"2022","journal-title":"Endocr Connect"},{"key":"10.1016\/j.heliyon.2023.e22819_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamainternmed.2015.1573","article-title":"Comparative safety of testosterone dosage forms","volume":"175","author":"Layton","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e22819_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-med-050219-034711","article-title":"Benefits and risks of testosterone treatment in men with age-related decline in testosterone","volume":"72","author":"Rodrigues Dos Santos","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.heliyon.2023.e22819_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/andr.13108","article-title":"Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age","volume":"10","author":"Pastuszak","year":"2022","journal-title":"Andrology"},{"key":"10.1016\/j.heliyon.2023.e22819_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2021.06.026","article-title":"Is a fasting testosterone level really necessary for the determination of androgen status in men?","volume":"521","author":"Livingston","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2023.e22819_bib20","doi-asserted-by":"crossref","first-page":"c4014","DOI":"10.1136\/bmj.c4014","article-title":"Transdermal testosterone gel. Don't take blood from the arm where gel is applied","volume":"341","author":"Nizar","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e22819_bib21","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1345\/aph.1R543","article-title":"Spuriously elevated testosterone measurements caused by application of testosterone gel at or near the phlebotomy site","volume":"47","author":"Kirk","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e22819_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114280","article-title":"Steroid profiling by UHPLC-MS\/MS in dried blood spots collected from healthy women with and without testosterone gel administration","volume":"204","author":"Salamin","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2023.e22819_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1515\/jpem-2012-0067","article-title":"Central precocious puberty after interpersonal transfer of testosterone gel: just a coincidence?","volume":"25","author":"Brachet","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2023.e22819_bib24","doi-asserted-by":"crossref","first-page":"c2319","DOI":"10.1136\/bmj.c2319","article-title":"Sexual precocity in a 4 year old boy","volume":"340","author":"Mason","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e22819_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2265.2002.01529.x","article-title":"Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation","volume":"56","author":"Rolf","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.heliyon.2023.e22819_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1373\/clinchem.2018.294538","article-title":"Identifying and eliminating laboratory contamination by topical testosterone Therapeutics","volume":"65","author":"Genzen","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.heliyon.2023.e22819_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/2374289517722152","article-title":"Using focused laboratory management and quality improvement projects to enhance resident training and foster scholarship","volume":"4","author":"Krasowski","year":"2017","journal-title":"Acad Pathol"},{"key":"10.1016\/j.heliyon.2023.e22819_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clinbiochem.2018.05.008","article-title":"How low can you go? Analytical performance of five automated testosterone immunoassays","volume":"58","author":"La'ulu","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.heliyon.2023.e22819_bib29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cca.2010.03.041","article-title":"Selected performance characteristics of the Roche Elecsys testosterone II assay on the Modular analytics E 170 analyzer","volume":"411","author":"Owen","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2023.e22819_bib30","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1373\/clinchem.2010.143222","article-title":"Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals","volume":"56","author":"Kushnir","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.heliyon.2023.e22819_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.21037\/tau.2016.07.10","article-title":"Pharmacology of testosterone replacement therapy preparations","volume":"5","author":"Shoskes","year":"2016","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.heliyon.2023.e22819_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/DHPS.S383130","article-title":"Safety aspects and rational use of testosterone undecanoate in the treatment of testosterone deficiency: clinical insights","volume":"15","author":"Campbell","year":"2023","journal-title":"Drug Healthc. Patient Saf."},{"key":"10.1016\/j.heliyon.2023.e22819_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12995","article-title":"Serum testosterone levels in male hypogonadism: why and when to check-A review","volume":"71","author":"Livingston","year":"2017","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.heliyon.2023.e22819_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1743-6109.2011.02265.x","article-title":"Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men","volume":"8","author":"Kaufman","year":"2011","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.heliyon.2023.e22819_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4158\/EP-2020-0414","article-title":"Serum hormone concentrations in transgender individuals receiving gender-affirming hormone therapy: a longitudinal retrospective cohort study","volume":"27","author":"Chantrapanichkul","year":"2021","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.heliyon.2023.e22819_bib36","unstructured":"Package Leaflet: Information for the User, Tostran 2% gel testosterone, Pharbil Waltrop GmbH, Retrieved on October 25, 2023 from, https:\/\/www.medicines.org.uk\/emc\/files\/pil.332.pdf."},{"key":"10.1016\/j.heliyon.2023.e22819_bib37","unstructured":"Product Monograph Testim 1%, Paladin Labs, Inc., Retrieved on October 25, 2023 from, https:\/\/www.paladin-labs.com\/our_products\/PM_Testim_EN.pdf."},{"key":"10.1016\/j.heliyon.2023.e22819_bib38","unstructured":"AndroGel Prescribing Information, Ascend Therapeutics, Retrieved on October 25, 2023 from, https:\/\/www.androgel.com\/prescribing-information."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023100272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023100272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:13:23Z","timestamp":1759616003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023100272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2405844023100272"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22819","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Falsely elevated serum testosterone measurements resulting from testosterone topical gel contamination of the venipuncture site: Case Series and retrospective review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e22819"}}